Kate Shaffar Group

Arteriovenous malformations can lead to severe complications if untreated. The Arteriovenous Malformation Market plays a critical role in providing hospitals and specialty centers with technologies for safe and effective interventions.

Minimally invasive procedures, advanced imaging, and patient-specific treatment planning have enhanced treatment efficacy. These factors are driving market growth by ensuring better patient outcomes and wider adoption globally.

Market Outlook: Valued at USD 1.1 billion in 2024, the market is expected to reach USD 2.4 billion by 2034, at a 7.0% CAGR.